Dr. Scott Richard Floyd, MD, PhD

Dr. Floyd practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Floyd's NPI, 1699746974, was assigned on January 27, 2006. Dr. Floyd graduated from Yale School of Medicine in 2002. Dr. Floyd holds North Carolina license 2015-01323.

Dr. Floyd's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Floyd's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Floyd is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Floyd to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Floyd practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Floyd's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Floyd is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Floyd's licenses on file in 3 states: North Carolina, Florida and Massachusetts.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation and lymphoma radiation among the conditions Dr. Floyd treats.

CMS data shows 409 Medicare services from Dr. Floyd across 9 procedure codes in 2024, for 57 Medicare patients. Medicare paid $32,706 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Dr. Floyd in 2024. The largest group is 65 to 74, with 28 patients. 72% of them have cancer, and 65% have high blood pressure. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Floyd's median patient age at 72, with 52% women.

In 2024, Dr. Floyd wrote 68 Medicare Part D claims for 32 patients. 96% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $209 in total drug cost. In 2022, CMS named 32 claims across 2 drugs.

Dr. Floyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Floyd as offering telehealth.

Dmand AI links 81 papers to Dr. Floyd, published from 2006 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Brain Neoplasms, Radiosurgery and DNA Damage. Dr. Floyd has published most often in Adv Radiat Oncol. Dr. Floyd's most frequent co-authors are John P. Kirkpatrick, MD, Zachary J. Reitman, MD, PhD and Trey Carlton Mullikin.

Dmand AI links Dr. Floyd to 2 clinical trials. Conditions studied include Brain Neoplasms and Central Nervous System Neoplasms. Duke University sponsors the most, 2.

CMS Open Payments shows 2 general payments to Dr. Floyd from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Zap Surgical Systems, Inc. paid the most, $363.

Dr. Floyd graduated from Yale School of Medicine in 2002.

Dr. Floyd is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.